ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

3 Small-Cap Stocks We’re Skeptical Of

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

COLM Cover Image

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here are three small-cap stocks to swipe left on and some alternatives you should look into instead.

Columbia Sportswear (COLM)

Market Cap: $3.19 billion

Originally founded as a hat store in 1938, Columbia Sportswear (NASDAQ: COLM) is a manufacturer of outerwear, sportswear, and footwear designed for outdoor enthusiasts.

Why Are We Out on COLM?

  1. Sales trends were unexciting over the last five years as its 5.8% annual growth was below the typical consumer discretionary company
  2. Poor free cash flow margin of 6.9% for the last two years limits its freedom to invest in growth initiatives, execute share buybacks, or pay dividends
  3. Shrinking returns on capital from an already weak position reveal that neither previous nor ongoing investments are yielding the desired results

At $62.41 per share, Columbia Sportswear trades at 16.8x forward P/E. Check out our free in-depth research report to learn more about why COLM doesn’t pass our bar.

Privia Health (PRVA)

Market Cap: $3.12 billion

Operating in 13 states and the District of Columbia with over 4,300 providers serving more than 4.8 million patients, Privia Health (NASDAQ: PRVA) is a technology-driven company that helps physicians optimize their practices, improve patient experiences, and transition to value-based care models.

Why Are We Cautious About PRVA?

  1. Modest revenue base of $2.12 billion gives it less fixed cost leverage and fewer distribution channels than larger companies
  2. Push for growth has led to negative returns on capital, signaling value destruction

Privia Health’s stock price of $24.85 implies a valuation ratio of 22.8x forward P/E. If you’re considering PRVA for your portfolio, see our FREE research report to learn more.

Applied Digital (APLD)

Market Cap: $9.79 billion

Pivoting from its origins in cryptocurrency mining to become a key player in the AI infrastructure boom, Applied Digital (NASDAQ: APLD) designs and operates specialized data centers that provide high-performance computing infrastructure for artificial intelligence and blockchain applications.

Why Does APLD Worry Us?

  1. Issuance of new shares over the last four years caused its earnings per share to fall by 3.7% annually while its revenue grew
  2. Cash-burning history makes us doubt the long-term viability of its business model
  3. Depletion of cash reserves could lead to a fundraising event that triggers shareholder dilution

Applied Digital is trading at $34.14 per share, or 41.5x forward EV-to-EBITDA. Read our free research report to see why you should think twice about including APLD in your portfolio.

High-Quality Stocks for All Market Conditions

WHILE YOU’RE HERE: Top 9 Market-Beating Stocks. The best stocks don't just beat the market once. They do it again. And again. Robust revenue growth, rising free cash flow, returns on capital that leave their competition in the dust. The market has already rewarded these businesses.

But our AI platform says the party isn't over. Find out which 9 stocks made the cut this week - FREE. Get Our Top 9 Market-Beating Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  269.60
+4.54 (1.71%)
AAPL  280.93
+9.58 (3.53%)
AMD  362.11
+7.62 (2.15%)
BAC  53.30
-0.16 (-0.30%)
GOOG  381.75
-0.19 (-0.05%)
META  611.27
-0.64 (-0.10%)
MSFT  414.74
+6.96 (1.71%)
NVDA  199.13
-0.44 (-0.22%)
ORCL  172.15
+10.76 (6.66%)
TSLA  396.68
+15.05 (3.94%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.